Folitixorin Calcium

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameFolitixorin Calcium
Drug Alias Name福酸林Fotrexorin calciumfolitixorinum福立替索林folitixorine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsRectal NeoplasmsColonic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFormer Serbia and MontenegroUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMast Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheragence IncMast Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRectal NeoplasmsColonic NeoplasmsColorectal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG